Main Session
Sep
28
PQA 02 - Lung Cancer/Thoracic Malignancies, Patient Reported Outcomes/QoL/Survivorship, Pediatric Cancer
2333 - Concurrent Immunotherapy Improves Progression-Free Survival but Increases Toxicity in Unresectable Stage III NSCLC
Presenter(s)
Dawei Chen, MD, MB - Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan, Shandong